139 related articles for article (PubMed ID: 15561798)
41. p38 Mitogen-activated protein kinase mediates synergistic induction of inducible nitric-oxide synthase by lipopolysaccharide and interferon-gamma through signal transducer and activator of transcription 1 Ser727 phosphorylation in murine aortic endothelial cells.
Huang H; Rose JL; Hoyt DG
Mol Pharmacol; 2004 Aug; 66(2):302-11. PubMed ID: 15266021
[TBL] [Abstract][Full Text] [Related]
42. Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB.
Whan Han J; Gon Lee B; Kee Kim Y; Woo Yoon J; Kyoung Jin H; Hong S; Young Lee H; Ro Lee K; Woo Lee H
Br J Pharmacol; 2001 Jun; 133(4):503-12. PubMed ID: 11399667
[TBL] [Abstract][Full Text] [Related]
43. Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages.
Kim IT; Ryu S; Shin JS; Choi JH; Park HJ; Lee KT
J Cell Biochem; 2012 Jun; 113(6):1936-46. PubMed ID: 22234926
[TBL] [Abstract][Full Text] [Related]
44. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Kato H; Imai T; Marumo F; Hirata Y
Endocrinology; 1999 May; 140(5):2183-90. PubMed ID: 10218970
[TBL] [Abstract][Full Text] [Related]
45. Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF-κB translocation.
Zheng GM; Yu C; Yang Z
Int J Oncol; 2012 May; 40(5):1610-8. PubMed ID: 22246431
[TBL] [Abstract][Full Text] [Related]
46. Doxycycline modulates nitric oxide production in murine lung epithelial cells.
Hoyt JC; Ballering J; Numanami H; Hayden JM; Robbins RA
J Immunol; 2006 Jan; 176(1):567-72. PubMed ID: 16365451
[TBL] [Abstract][Full Text] [Related]
47. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells.
Oh JH; Lee TJ; Park JW; Kwon TK
Eur J Pharmacol; 2008 Dec; 599(1-3):11-7. PubMed ID: 18838070
[TBL] [Abstract][Full Text] [Related]
48. Ligustilide prevents LPS-induced iNOS expression in RAW 264.7 macrophages by preventing ROS production and down-regulating the MAPK, NF-κB and AP-1 signaling pathways.
Su YW; Chiou WF; Chao SH; Lee MH; Chen CC; Tsai YC
Int Immunopharmacol; 2011 Sep; 11(9):1166-72. PubMed ID: 21457761
[TBL] [Abstract][Full Text] [Related]
49. Anti-inflammatory effects of sophocarpine in LPS-induced RAW 264.7 cells via NF-κB and MAPKs signaling pathways.
Gao Y; Jiang W; Dong C; Li C; Fu X; Min L; Tian J; Jin H; Shen J
Toxicol In Vitro; 2012 Feb; 26(1):1-6. PubMed ID: 21978812
[TBL] [Abstract][Full Text] [Related]
50. Essential role of mitogen-activated protein kinase pathways in protease activated receptor 2-mediated nitric-oxide production from rat primary astrocytes.
Park GH; Jeon SJ; Ryu JR; Choi MS; Han SH; Yang SI; Ryu JH; Cheong JH; Shin CY; Ko KH
Nitric Oxide; 2009 Sep; 21(2):110-9. PubMed ID: 19527794
[TBL] [Abstract][Full Text] [Related]
51. Expression of a dominant negative inhibitor of NF-kappaB protects MIN6 beta-cells from cytokine-induced apoptosis.
Baker MS; Chen X; Cao XC; Kaufman DB
J Surg Res; 2001 May; 97(2):117-22. PubMed ID: 11341786
[TBL] [Abstract][Full Text] [Related]
52. Human NK cells express endothelial nitric oxide synthase, and nitric oxide protects them from activation-induced cell death by regulating expression of TNF-alpha.
Furuke K; Burd PR; Horvath-Arcidiacono JA; Hori K; Mostowski H; Bloom ET
J Immunol; 1999 Aug; 163(3):1473-80. PubMed ID: 10415049
[TBL] [Abstract][Full Text] [Related]
53. Alpha 2-macroglobulin functions as a cytokine carrier to induce nitric oxide synthesis and cause nitric oxide-dependent cytotoxicity in the RAW 264.7 macrophage cell line.
Lysiak JJ; Hussaini IM; Webb DJ; Glass WF; Allietta M; Gonias SL
J Biol Chem; 1995 Sep; 270(37):21919-27. PubMed ID: 7545171
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory Effects of Polydatin on Lipopolysaccharide-Stimulated RAW 264.7 Cells.
Lou T; Jiang W; Xu D; Chen T; Fu Y
Inflammation; 2015; 38(3):1213-20. PubMed ID: 25567371
[TBL] [Abstract][Full Text] [Related]
55. Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-kappaB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells.
Kim JH; Kim DH; Baek SH; Lee HJ; Kim MR; Kwon HJ; Lee CH
Biochem Pharmacol; 2006 Apr; 71(8):1198-205. PubMed ID: 16457781
[TBL] [Abstract][Full Text] [Related]
56. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
Chang PC; Chen TH; Chang CJ; Hou CC; Chan P; Lee HM
Kidney Int; 2004 May; 65(5):1664-75. PubMed ID: 15086905
[TBL] [Abstract][Full Text] [Related]
57. Kaempferol 7-O-β-D-glucoside isolated from the leaves of Cudrania tricuspidata inhibits LPS-induced expression of pro-inflammatory mediators through inactivation of NF-κB, AP-1, and JAK-STAT in RAW 264.7 macrophages.
Lee SB; Shin JS; Han HS; Lee HH; Park JC; Lee KT
Chem Biol Interact; 2018 Mar; 284():101-111. PubMed ID: 29470957
[TBL] [Abstract][Full Text] [Related]
58. Protein kinase Cdelta and protein tyrosine kinase regulate peptidoglycan-induced nuclear factor-kappaB activation and inducible nitric oxide synthase expression in mouse peritoneal macrophages in vitro.
Bhatt KH; Pandey RK; Dahiya Y; Sodhi A
Mol Immunol; 2010 Jan; 47(4):861-70. PubMed ID: 19931912
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by phenolic (3E)-4-(2-hydroxyphenyl)but-3-en-2-one in RAW 264.7 macrophages.
Tsao LT; Tsai PS; Lin RH; Huang LJ; Kuo SC; Wang JP
Biochem Pharmacol; 2005 Aug; 70(4):618-26. PubMed ID: 15998510
[TBL] [Abstract][Full Text] [Related]
60. Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages.
Vicente AM; Guillén MI; Alcaraz MJ
Br J Pharmacol; 2001 Jul; 133(6):920-6. PubMed ID: 11454666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
